30.2 C
New York
Sunday, June 14, 2026

Tag: X

AGIBOT Brings APC 2026 to Indonesia, Accelerating Local Deployment of Embodied AI

JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- AGIBOT, a global leader in embodied AI and robotics, hosted AGIBOT Partner Conference 2026 in Indonesia (APC...

USPS American Icons Commemorative Stamp Collection Curated by Ralph Lauren Marks America’s 250th Anniversary

Postal Service and Ralph Lauren dedicate American Icons in unveiling ceremonyNEW YORK, June 9, 2026 /PRNewswire/ -- The U.S. Postal Service today honored the...

Bybit TradFi Doubles Down on Zero-Fee Stock CFD Trading: 0 Commission + 0 Swap Fee

DUBAI, UAE, June 9, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is making stock CFD trading completely free via...

Ally Medical ER Is Coming to Magnolia

Ally Medical Emergency Room is opening in Magnolia, TX near FM 1488 in 2027 — 24/7 care, board-certified physicians, no wait times for Montgomery County.

Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)

Longeveron (LGVN) granted Small or Medium-sized Enterprise (SME) status by the European Medicines Agency (EMA).

DNV Validates Fluence 99% Fleet Performance Availability for Large Energy Storage Projects

Comprehensive DNV analysis confirms strong operational performance, providing a verified benchmark for consistent uptime and revenue support
Comprehensive DNV analysis confirms strong operational performance, providing a verified benchmark for consistent uptime and revenue support

Cetera Welcomes Former Commonwealth Advisors David Cushard, Wesley Mullins, and Their Team, with Approximately $190 Million in AUA

After a deliberate search for the Commonwealth experience, experienced advisors find their answer inCetera's unique Summit communitySAN DIEGO, June 9, 2026 /PRNewswire/ -- Cetera welcomes...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

Errington Metals Reports Strong 2025 Drill Results and Further Defines Expansion Potential at Errington Zone

THUNDER BAY, ON, June 9, 2026 /CNW/ - Errington Metals Corp. (TSXV: EM) ("Errington" or the "Company") is pleased to report results from its...

Lithia & Driveway (LAD) Rises to Number 123 on 2026 Fortune 500 List

Lithia & Driveway (LAD) Rises to Number 123 on 2026 Fortune 500 List

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

Transaction in Own Shares

Transaction in Own Shares

Valmet’s solution boosts Gren Tartu’s district heating capacity in Estonia with flue gas heat recovery

Valmet Oyj's press release June 9, 2026, at 10:00 a.m. EESTESPOO, Finland, June 9, 2026 /PRNewswire/ -- Valmet has received an order from Gren...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsX